Flunarizine

Thông số

52468-60-7Số CAS

257-937-5Số EC

1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazineTên IUPAC

C26H26F2N2Công thức hóa học

404.5 g/molKhối lượng phân tử

flunarizine; 52468-60-7; Sibelium; Flunarizina; Flunarizinum; DTXSID6045616; R7PLA2DM0J; 1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine; 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine; Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, (E)-; DTXCID4025616; Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-, (E)-; Flunarizin; R14950; 1-(bis(4-fluorophenyl)methyl)-4-((2E)-3-phenylprop-2-en-1-yl)piperazine; 1-(bis(4-fluorophenyl)methyl)-4-((E)-3-phenylprop-2-enyl)piperazine; RefChem:5832; N07CA03; 257-937-5; 1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine; Flunarizinum [INN-Latin]; Flunarizina [INN-Spanish]; Flunarizine (INN); (Z)-Flunarizine; (E)-1-(Bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)piperazine; CHEMBL30008; (E)-1-[Bis-(p-fluorophenyl)methyl]-4-cinnamylpiperazine; 1-[bis(4-fluorophenyl)methyl]-4-[(E)-cinnamyl]piperazine; FLUNARIZINE [INN]; (e)-1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine; Flunarizine [INN:BAN]; Narzine; Flunarizine (dihydrochloride); 4-((2E)-3-phenylprop-2-enyl)-1-[bis(4-fluorophenyl)methyl]piperazine; Sibelium (TN); CAS-52468-60-7; C26H26F2N2; EINECS 257-937-5; UNII-R7PLA2DM0J; (E)-1-(BIS-(P-FLUOROPHENYL)METHYL)-4-CINNAMYLPIPERAZINE; Flunarizine2HCl; NCGC00018102-06; EINECS 254-842-0; Flunarizine (Standard); FLUNARIZINE [MI]; Prestwick2_000312; Prestwick3_000312; Spectrum5_001570; Lopac0_000527; SCHEMBL43440; 4',4''-Difluorocinnarizine; BSPBio_000304; BSPBio_001341; BSPBio_003096; FLUNARIZINE [WHO-DD]; 1-[bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine; BPBio1_000336; orb1705085; orb3025532; BCBcMAP01_000120; CHEBI:92209; cid_6365505; GTPL12488; HY-B0358R; CHEBI:135652; GLXC-20231; HMS1361D03; HMS1791D03; HMS1989D03; HMS2089H21; HY-B0358; Tox21_110825; BDBM50017702; EBC-26967; MFCD00242731; Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-; 1-[Bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]piperazine; AKOS015960783; Tox21_110825_1; AC-1283; CCG-204617; DB04841; SDCCGSBI-0050510.P004; IDI1_000043; IDI1_033811; NCGC00018102-04; NCGC00018102-05; NCGC00018102-07; NCGC00018102-08; NCGC00018102-09; NCGC00018102-10; NCGC00018102-12; NCGC00018102-24; NCGC00024308-04; NCGC00024308-05; NCGC00024308-06; NCGC00024308-07; AS-75845; ST024768; SBI-0050510.P003; CS-0013608; NS00003460; D07971; D93478; T21392; AB00053586-15; AB00053586_16; AB00053586_17; EN300-22842458; F817460; Q416237; 1-[bis(4-fluorophenyl)methyl]-4-cinnamyl- piperazine; BRD-K12184470-300-01-8; BRD-K29582677-001-02-7; BRD-K29582677-300-05-6; BRD-K29582677-300-06-4; BRD-K29582677-300-08-0; BRD-K29582677-300-09-8; BRD-K29582677-300-10-6; 1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine;; 1-[Bis-(4-fluoro-phenyl)-methyl]-4-(3-phenyl-allyl)-piperazine; 1-[Bis-(4-fluoro-phenyl)-methyl]-4-((E)-3-phenyl-allyl)-piperazine; Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]-; 1-[Bis-(4-fluoro-phenyl)-methyl]-4-(3-phenyl-allyl)-piperazine(Flunarizine)Tên gọi khác